Company Data
Outlook Therapeutics Inc.
Ticker
OTLK
Current Price
$2.07 2.48%
Market Cap
$69.5M
Price Target
Refer to Report
Volume
1.6M
52wk Range
$0.87 - $9.25
Overview
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.